The goal of this study was to deepen the understanding of TME, evaluating the spatial distribution of tumour-infiltrating immune cells, adding special emphasis on PD-L1+ lymphocytes and their association with the tumour-immune phenotype, as well as PD-L1 expression and prognosis. The gene discussed is CD274; the disease is neoplasm.